• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CTY
Share

City Therapeutics Stocks

¤ 0Last Updated 16.10.2026

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

16.10.2026 15:00

IPO City: A biotech company developing "switches" to turn off harmful genes has gone public

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 15:56

Morning in New York: Rotation Supports the Market Amid AI Challenges

16.10.2026 15:10

European stocks are heading toward their widest gap from U.S. stocks since March

16.10.2026 15:00

IPO City: A biotech company developing "switches" to turn off harmful genes has gone public

16.10.2026 13:40

Netflix Replaced Its Chief Content Officer After Its Stock Price Fell 40% Over the Past Year

16.10.2026 12:40

CoreWeave's founders protected their fortunes by selling $3.3 billion worth of shares

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026